scholarly journals Cost-Effectiveness of Postoperative Drug Rehabilitation for Injection Drug Users

2020 ◽  
Vol 110 (2) ◽  
pp. 492-499 ◽  
Author(s):  
Zachary Tyerman ◽  
Shawn Shah ◽  
J. Hunter Mehaffey ◽  
Tanya Wanchek ◽  
Robert B. Hawkins ◽  
...  
PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e45176 ◽  
Author(s):  
Lauren E. Cipriano ◽  
Gregory S. Zaric ◽  
Mark Holodniy ◽  
Eran Bendavid ◽  
Douglas K. Owens ◽  
...  

2021 ◽  
Vol 22 (2) ◽  
Author(s):  
Shima Bordbar ◽  
Hassan Joulaei ◽  
Abdosaleh Jafari ◽  
Mehrdad Askarian ◽  
Charles John Palenik ◽  
...  

Background: Acquired immunodeficiency syndrome is a behavioral disorder that can be detected via two methods, including active and passive screening. Objectives: This study aimed to evaluate the cost-effectiveness of screening strategies of HIV/AIDS among injection drug users (IDUs) referring to the voluntary counseling and testing (VCT) center and drop-in center (DIC) of Shiraz University of Medical Sciences. Methods: This was a cross-sectional cost-effectiveness analysis to compare the cost-effectiveness of the two active and passive screening methods in 2015. The decision tree model, along with the TreeAge11 software, was used to analyze the data. Results: The averages of cost and effectiveness were $989 and 987 subjects in the active screening method while they were $1,767 and 209 subjects in the passive screening method, respectively. The incremental cost-effectiveness ratio (ICER) to early-diagnosed and averted cases was $855/39 for the active screening method and $1528/90 for the passive screening method. According to the findings of the study, the active screening method is more cost-effective than its passive counterpart. Conclusions: According to the findings of the study, the active screening method is more cost-effective than its passive counterpart, and it is recommended to be used in these cases.


2011 ◽  
Vol 203 (6) ◽  
pp. 847-853 ◽  
Author(s):  
Prem H. Thurairajah ◽  
Doha Hegazy ◽  
Andrew Demaine ◽  
Edward R. Kaminski ◽  
Matthew E. Cramp

2001 ◽  
Vol 21 (5) ◽  
pp. 357-367 ◽  
Author(s):  
Harold A. Pollack

Objectives. Hepatitis C (HCV) has emerged as a major epidemic among injection drug users (IDUs), with observed prevalence exceeding 70% in many American and European cities. This article explores the potential of syringe exchange programs (SEPs) to reduce HCV incidence and prevalence. Design. A random-mixing epidemiological model is used to examine the potential impact of harm reduction interventions. Methods. Steady-state analysis is used to scrutinize the impact of SEP on HCV incidence and prevalence and to examine the accuracy of short-term incidence analysis in predicting long-run program effects. Results. SEP is predicted to have little impact on HCV incidence and prevalence within realistic populations of IDUs. Conclusions. Short-term incidence analysis substantially overstates SEP effectiveness and cost-effectiveness in preventing HCV. More comprehensive harm reduction models, coupled with referral of active IDUs to treatment, must complement syringe exchange to successfully contain highly infectious blood-borne diseases.


2001 ◽  
Vol 120 (5) ◽  
pp. A568-A568
Author(s):  
D SYLVESTRE ◽  
R ARON ◽  
D GREENE ◽  
P PERKINS

Sign in / Sign up

Export Citation Format

Share Document